Navigation Links
PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress
Date:11/4/2008

PRA discusses drivers of study success at Berlin conference

RALEIGH, N.C., Nov. 4 /PRNewswire/ -- PRA International, a leading Clinical Research Organization announces it will present during the Partnerships in Clinical Trials Congress, 4 - 7 November, 2008 in Berlin, Germany. PRA's Christian Tucat, Senior Vice President of Business Development - Europe, will present "What's next in the evolution of CRO partnerships?" at 4PM on Wednesday, 5 November. Drawing on his extensive experience, Mr. Tucat will discuss strategic options for governance and Sponsor-CRO partnering that optimizes clinical study success.

PRA provides outsourced clinical services across all phases of pharmaceutical and biotech drug development. It conducts clinical trials in more than 60 countries across six continents. Operating in Europe for over 27 years, PRA has executed over 1,000 studies through its 15 European offices. PRA's capabilities in Europe include:

-- Clinical operations staff providing coverage of 38 European countries

for Phase II through Phase IV studies

-- Two 70 bed Phase I units

-- An innovative "virtual Phase I" model in central Europe

-- A world class bioanalytical laboratory

PRA will have several therapeutic and clinical experts in attendance at the Partnerships in Clinical Trials Congress, including global leaders of Oncology and Early Development Services.

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Oncology, CNS, respiratory/allergy diseases, cardiovascular and infectious diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 30 global offices. PRA's therapeutic expertise, global reach, and project experience with local knowledge enable our project teams to deliver consistent and on time performance for our clients.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
3. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
4. Arrow International Files and Mails Definitive Proxy Materials
5. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
6. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
7. Viragen International to Reverse Split Its Common Stock
8. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
9. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
10. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
11. Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , ... December 02, 2016 ... ... a consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing improved ... interested in supplying a vendor-supported, portable online UHPLC, with robust, probe-based sampling. ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected ... of 7.3% during the forecast period of 2016 to 2021 dominated ... accounted for the largest share of immunohistochemistry (IHC) market, by end ... , , ... market spread across 225 pages, profiling 10 companies and supported with ...
(Date:11/30/2016)... today announced the appointment of Joshua F. Coleman , ... Dr. Coleman will oversee clinical content development and curation of ... software suite empowers molecular pathologists with a seamless workflow for ... from quality control through reporting. ... , , ...
(Date:11/30/2016)... RATON, Fla. , Nov. 30, 2016 ... biotherapeutic products, is pleased to announce the addition of ... Avenue Kearney, Nebraska . The 15,200 ... business on November 29th, 2016 and brings the total ... Ileana Carlisle , BPC,s Chief Executive ...
Breaking Biology Technology:
(Date:11/21/2016)... , Nov. 21, 2016   Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...
(Date:11/15/2016)... Md. , Nov. 15, 2016  Synthetic ... company developing therapeutics focused on the gut microbiome, ... offering of 25,000,000 shares of its common stock ... common stock at a price to the public ... proceeds to Synthetic Biologics from the offering, excluding ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
Breaking Biology News(10 mins):